Approved for Use By both the World Health Organization’s International Nonproprietary Names (WHO-INN) and the American Medical Association’s United States Adopted Names (AMA-USAN) Council SAN DIEGO, March 12, 2026 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical?stage biotechnology…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
